news

You may have never heard of biosimilar drugs and that’s probably because they are not commonly prescribed in the United States even though they have been around for over 20 years. So, what are biosimilar drugs? A biosimilar drug is no different in terms of safety and effectiveness than a biologic product, also known as a reference product, and while highly similar it is not identical.

In the early 2000s, the FDA set up guidelines in the Regulatory Procedures Manual (RPM) that permitted prescription drugs to be imported from other countries if the patient met very strict guidelines. Just stating that the patient needed the drug due to cost savings was not a justification to obtain the drug.

PBMs are fulfilling their primary mission to lower prescription drug costs for consumers and health plan sponsors, says PCMA CEO.

VativoRx recently participated in the SIIA Future Leaders Forum in April 2022.

Mom and Pop pharmacies are thriving. A recent study showed the number of independent pharmacies in the United States growing 12.9% from 2010 to 2019. 

For a lot of people, their first choice is a so-called “Mom and Pop” business that may be slightly smaller and more focused on personal service.

Going forward, generic drugs may be more difficult to manufacture, due to the nature of the medicines they aim to replicate.

While most of us are deeply familiar the patient’s journey, sometimes that process may not be as clear as it could be.

At a recent industry conference, the number one topic attendees wanted to learn more about was price transparency.